HEADER HYDROLASE 22-APR-17 5NRF TITLE CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 (HCHIT) CATALYTIC DOMAIN TITLE 2 IN COMPLEX WITH COMPOUND 7I COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITOTRIOSIDASE-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CHITINASE-1; COMPND 5 EC: 3.2.1.14; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHIT1; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS CHITOTRIOSIDASE-1 (HCHIT) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND KEYWDS 2 7I, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI, AUTHOR 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.SKLEPKIEWICZ,A.ZAGOZDZON, AUTHOR 3 T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER,P.BECKETT,W.M.HUNGERFORD, AUTHOR 4 A.PODJARNY,A.MITSCHLER,A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI REVDAT 2 13-NOV-24 5NRF 1 REMARK REVDAT 1 28-MAR-18 5NRF 0 JRNL AUTH M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI, JRNL AUTH 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.L.SKLEPKIEWICZ, JRNL AUTH 3 A.ZAGOZDZON,T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER, JRNL AUTH 4 P.BECKETT,W.M.HUNGERFORD,A.PODJARNY,A.MITSCHLER, JRNL AUTH 5 A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI JRNL TITL TARGETING ACIDIC MAMMALIAN CHITINASE IS EFFECTIVE IN ANIMAL JRNL TITL 2 MODEL OF ASTHMA. JRNL REF J. MED. CHEM. V. 61 695 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29283260 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01051 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.MAZUR,J.OLCZAK,S.OLEJNICZAK,R.KORALEWSKI,W.CZESTKOWSKI, REMARK 1 AUTH 2 A.JEDRZEJCZAK,J.GOLAB,K.DZWONEK,B.DYMEK,P.SKLEPKIEWICZ, REMARK 1 AUTH 3 A.ZAGOZDZON,T.NOONAN,K.MAHBOUBI,B.CONWAY,R.SHEELER, REMARK 1 AUTH 4 P.BECKETT,W.M.HUNGERFORD,A.PODJARNY,A.MITSCHLER, REMARK 1 AUTH 5 A.COUSIDO-SIAH,F.FADEL,A.GOLEBIOWSKI REMARK 1 TITL TARGETING ACIDIC MAMMALIAN CHITINASE IS EFFECTIVE IN ANIMAL REMARK 1 TITL 2 MODEL OF ASTHMA REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1255 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 67781 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.145 REMARK 3 R VALUE (WORKING SET) : 0.144 REMARK 3 FREE R VALUE : 0.169 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3422 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.9346 - 4.1713 0.97 2905 122 0.1559 0.1481 REMARK 3 2 4.1713 - 3.3124 0.98 2747 162 0.1532 0.1650 REMARK 3 3 3.3124 - 2.8941 0.99 2771 146 0.1646 0.1795 REMARK 3 4 2.8941 - 2.6297 0.99 2745 139 0.1701 0.2109 REMARK 3 5 2.6297 - 2.4413 0.99 2758 136 0.1591 0.1632 REMARK 3 6 2.4413 - 2.2975 0.98 2709 148 0.1500 0.1820 REMARK 3 7 2.2975 - 2.1824 0.99 2689 168 0.1371 0.1466 REMARK 3 8 2.1824 - 2.0875 0.99 2698 140 0.1292 0.1567 REMARK 3 9 2.0875 - 2.0071 0.98 2691 141 0.1213 0.1586 REMARK 3 10 2.0071 - 1.9379 0.99 2682 144 0.1235 0.1544 REMARK 3 11 1.9379 - 1.8773 0.98 2688 143 0.1174 0.1604 REMARK 3 12 1.8773 - 1.8236 0.98 2663 161 0.1216 0.1665 REMARK 3 13 1.8236 - 1.7756 0.98 2672 144 0.1182 0.1760 REMARK 3 14 1.7756 - 1.7323 0.98 2646 160 0.1223 0.1543 REMARK 3 15 1.7323 - 1.6929 0.98 2636 139 0.1247 0.1920 REMARK 3 16 1.6929 - 1.6569 0.97 2657 150 0.1228 0.1643 REMARK 3 17 1.6569 - 1.6238 0.98 2624 141 0.1224 0.1620 REMARK 3 18 1.6238 - 1.5931 0.98 2698 113 0.1236 0.1963 REMARK 3 19 1.5931 - 1.5647 0.97 2580 148 0.1191 0.1568 REMARK 3 20 1.5647 - 1.5382 0.97 2678 139 0.1308 0.1868 REMARK 3 21 1.5382 - 1.5134 0.97 2602 130 0.1364 0.2113 REMARK 3 22 1.5134 - 1.4901 0.97 2664 134 0.1456 0.1825 REMARK 3 23 1.4901 - 1.4682 0.97 2603 140 0.1559 0.1892 REMARK 3 24 1.4682 - 1.4475 0.94 2553 134 0.1715 0.2242 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 14.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 3298 REMARK 3 ANGLE : 1.169 4483 REMARK 3 CHIRALITY : 0.077 458 REMARK 3 PLANARITY : 0.005 585 REMARK 3 DIHEDRAL : 14.394 1194 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NRF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-APR-17. REMARK 100 THE DEPOSITION ID IS D_1200004595. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67782 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 28.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.3200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) POLYETHYLENE GLYCOL (PEG) REMARK 280 3350, 200 MM POTASSIUM SODIUM TARTRATE (PST) AT PH 7.2, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 42.82200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.99850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.82200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.99850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 305 N CA C O CB CG CD REMARK 480 GLU A 305 OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 226 64.49 -155.31 REMARK 500 THR A 266 34.49 -95.20 REMARK 500 ASP A 328 -125.05 53.80 REMARK 500 ASP A 328 -125.05 52.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 95Q A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 DBREF 5NRF A 22 387 UNP Q13231 CHIT1_HUMAN 22 387 SEQADV 5NRF VAL A 388 UNP Q13231 EXPRESSION TAG SEQADV 5NRF PRO A 389 UNP Q13231 EXPRESSION TAG SEQADV 5NRF ARG A 390 UNP Q13231 EXPRESSION TAG SEQADV 5NRF GLY A 391 UNP Q13231 EXPRESSION TAG SEQADV 5NRF SER A 392 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 393 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 394 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 395 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 396 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 397 UNP Q13231 EXPRESSION TAG SEQADV 5NRF HIS A 398 UNP Q13231 EXPRESSION TAG SEQRES 1 A 377 ALA LYS LEU VAL CYS TYR PHE THR ASN TRP ALA GLN TYR SEQRES 2 A 377 ARG GLN GLY GLU ALA ARG PHE LEU PRO LYS ASP LEU ASP SEQRES 3 A 377 PRO SER LEU CYS THR HIS LEU ILE TYR ALA PHE ALA GLY SEQRES 4 A 377 MET THR ASN HIS GLN LEU SER THR THR GLU TRP ASN ASP SEQRES 5 A 377 GLU THR LEU TYR GLN GLU PHE ASN GLY LEU LYS LYS MET SEQRES 6 A 377 ASN PRO LYS LEU LYS THR LEU LEU ALA ILE GLY GLY TRP SEQRES 7 A 377 ASN PHE GLY THR GLN LYS PHE THR ASP MET VAL ALA THR SEQRES 8 A 377 ALA ASN ASN ARG GLN THR PHE VAL ASN SER ALA ILE ARG SEQRES 9 A 377 PHE LEU ARG LYS TYR SER PHE ASP GLY LEU ASP LEU ASP SEQRES 10 A 377 TRP GLU TYR PRO GLY SER GLN GLY SER PRO ALA VAL ASP SEQRES 11 A 377 LYS GLU ARG PHE THR THR LEU VAL GLN ASP LEU ALA ASN SEQRES 12 A 377 ALA PHE GLN GLN GLU ALA GLN THR SER GLY LYS GLU ARG SEQRES 13 A 377 LEU LEU LEU SER ALA ALA VAL PRO ALA GLY GLN THR TYR SEQRES 14 A 377 VAL ASP ALA GLY TYR GLU VAL ASP LYS ILE ALA GLN ASN SEQRES 15 A 377 LEU ASP PHE VAL ASN LEU MET ALA TYR ASP PHE HIS GLY SEQRES 16 A 377 SER TRP GLU LYS VAL THR GLY HIS ASN SER PRO LEU TYR SEQRES 17 A 377 LYS ARG GLN GLU GLU SER GLY ALA ALA ALA SER LEU ASN SEQRES 18 A 377 VAL ASP ALA ALA VAL GLN GLN TRP LEU GLN LYS GLY THR SEQRES 19 A 377 PRO ALA SER LYS LEU ILE LEU GLY MET PRO THR TYR GLY SEQRES 20 A 377 ARG SER PHE THR LEU ALA SER SER SER ASP THR ARG VAL SEQRES 21 A 377 GLY ALA PRO ALA THR GLY SER GLY THR PRO GLY PRO PHE SEQRES 22 A 377 THR LYS GLU GLY GLY MET LEU ALA TYR TYR GLU VAL CYS SEQRES 23 A 377 SER TRP LYS GLY ALA THR LYS GLN ARG ILE GLN ASP GLN SEQRES 24 A 377 LYS VAL PRO TYR ILE PHE ARG ASP ASN GLN TRP VAL GLY SEQRES 25 A 377 PHE ASP ASP VAL GLU SER PHE LYS THR LYS VAL SER TYR SEQRES 26 A 377 LEU LYS GLN LYS GLY LEU GLY GLY ALA MET VAL TRP ALA SEQRES 27 A 377 LEU ASP LEU ASP ASP PHE ALA GLY PHE SER CYS ASN GLN SEQRES 28 A 377 GLY ARG TYR PRO LEU ILE GLN THR LEU ARG GLN GLU LEU SEQRES 29 A 377 SER LEU VAL PRO ARG GLY SER HIS HIS HIS HIS HIS HIS HET 95Q A 401 29 HET GOL A 402 12 HETNAM 95Q 1-(3-AZANYL-1~{H}-1,2,4-TRIAZOL-5-YL)-~{N}-[2-(4- HETNAM 2 95Q CHLOROPHENYL)ETHYL]-~{N}-(PHENYLMETHYL)PIPERIDIN-4- HETNAM 3 95Q AMINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 95Q C22 H27 CL N6 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *200(H2 O) HELIX 1 AA1 TRP A 31 ARG A 35 5 5 HELIX 2 AA2 GLN A 36 ARG A 40 5 5 HELIX 3 AA3 LEU A 42 LEU A 46 5 5 HELIX 4 AA4 ASN A 72 ASN A 87 1 16 HELIX 5 AA5 THR A 103 ALA A 111 1 9 HELIX 6 AA6 THR A 112 SER A 131 1 20 HELIX 7 AA7 VAL A 150 GLY A 174 1 25 HELIX 8 AA8 GLY A 187 TYR A 195 1 9 HELIX 9 AA9 GLU A 196 LEU A 204 1 9 HELIX 10 AB1 SER A 235 LEU A 241 5 7 HELIX 11 AB2 ASN A 242 LYS A 253 1 12 HELIX 12 AB3 PRO A 256 SER A 258 5 3 HELIX 13 AB4 TYR A 303 CYS A 307 1 5 HELIX 14 AB5 ASP A 336 LYS A 350 1 15 HELIX 15 AB6 ALA A 359 ASP A 363 5 5 HELIX 16 AB7 TYR A 375 LEU A 385 1 11 SHEET 1 AA110 GLN A 65 SER A 67 0 SHEET 2 AA110 HIS A 53 THR A 62 -1 N GLY A 60 O SER A 67 SHEET 3 AA110 LYS A 91 GLY A 97 1 O ALA A 95 N ALA A 59 SHEET 4 AA110 GLY A 134 ASP A 138 1 O ASP A 136 N LEU A 94 SHEET 5 AA110 LEU A 179 PRO A 185 1 O ALA A 183 N LEU A 137 SHEET 6 AA110 PHE A 206 MET A 210 1 O ASN A 208 N ALA A 182 SHEET 7 AA110 LEU A 260 PRO A 265 1 O ILE A 261 N VAL A 207 SHEET 8 AA110 GLY A 354 TRP A 358 1 O MET A 356 N LEU A 262 SHEET 9 AA110 LYS A 23 THR A 29 1 N VAL A 25 O ALA A 355 SHEET 10 AA110 HIS A 53 THR A 62 1 O HIS A 53 N CYS A 26 SHEET 1 AA2 3 ALA A 285 SER A 288 0 SHEET 2 AA2 3 TYR A 267 LEU A 273 -1 N THR A 272 O GLY A 287 SHEET 3 AA2 3 MET A 300 ALA A 302 -1 O LEU A 301 N GLY A 268 SHEET 1 AA3 5 ALA A 285 SER A 288 0 SHEET 2 AA3 5 TYR A 267 LEU A 273 -1 N THR A 272 O GLY A 287 SHEET 3 AA3 5 GLN A 330 GLY A 333 -1 O TRP A 331 N PHE A 271 SHEET 4 AA3 5 VAL A 322 ARG A 327 -1 N ILE A 325 O VAL A 332 SHEET 5 AA3 5 THR A 313 ILE A 317 -1 N GLN A 315 O TYR A 324 SSBOND 1 CYS A 26 CYS A 51 1555 1555 2.04 SSBOND 2 CYS A 307 CYS A 370 1555 1555 2.04 CISPEP 1 ALA A 57 PHE A 58 0 -4.84 CISPEP 2 GLU A 140 TYR A 141 0 -5.29 CISPEP 3 TRP A 358 ALA A 359 0 0.90 SITE 1 AC1 19 TYR A 27 TRP A 99 ASP A 138 GLU A 140 SITE 2 AC1 19 ALA A 183 MET A 210 TYR A 212 ASP A 213 SITE 3 AC1 19 TYR A 267 ARG A 269 THR A 295 GLU A 297 SITE 4 AC1 19 MET A 300 MET A 356 TRP A 358 LEU A 362 SITE 5 AC1 19 ARG A 390 GLY A 391 HOH A 503 SITE 1 AC2 8 TYR A 141 PRO A 185 ALA A 186 GLY A 187 SITE 2 AC2 8 MET A 210 TYR A 212 ASP A 213 HOH A 501 CRYST1 85.644 105.997 42.236 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011676 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009434 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023676 0.00000